For this, the polymerization of Py was conducted in the presence of a target analyte (Carcinoembryonic antigen, CEA, a glycoprotein acting as cancer biomarker, selected for this first test) and followed by subsequent removal of that analyte (by enzymatic digestion). The gene discussed is CEACAM5; the disease is cancer.